Key result
Captopril completely reverses hypertension-augmented intracellular chloride reduction in rat cerebrovascular smooth muscle cells.
Answers are grounded in this paper and cite their sources.
The cerebrovascular remodeling is a prominent feature of hypertension and considered a major risk factor for stroke. Cerebrovascular smooth muscle cells meet volume challenge during this pathophysiological process. Our previous studies suggest that volume regulated chloride channels may be critical to the cell cycle of vascular smooth muscle cells. However, it is unknown whether the volume-regulated chloride movement is altered in hypertension. Therefore, we directly measured the concentration of intracellular chloride ([Cl(-)](i)) in rat basilar arterial smooth muscle cells isolated from control rats and rats that were made hypertensive for 1 to 12 weeks after partial renal artery constriction (2-kidney, 2-clip method) using a 6-methoxy-N-ethylquinolinium iodide fluorescence probe. The [Cl(-)](i) in isotonic solution showed no difference in all of the groups. After hypotonic perfusion, the reduction in [Cl(-)](i) was more prominent in hypertensive cerebrovascular smooth muscle cells than in sham control cells. Genistein, a protein tyrosine kinase inhibitor, inhibited hypotonic-induced reduction in [Cl(-)](i), whereas sodium orthovanadate, a protein-tyrosine phosphatase inhibitor, enhanced hypotonic-induced reduction in [Cl(-)](i) in both groups. The percentage inhibition of reduction in [Cl(-)](i) by genistein on volume-regulated chloride movement has a positive correlation with blood pressure levels in the 2-kidney, 2-clip hypertensive group, as is the case for the percentage increase of reduction in [Cl(-)](i) by sodium orthovanadate. Antihypertensive therapy with the angiotensin-converting enzyme inhibitor captopril completely reversed abnormal volume-regulated chloride movement in hypertensive rats. We conclude that volume-regulated chloride movement is augmented in rat cerebrovascular smooth muscle cells in proportion to the severity of hypertension.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2007) studied Hypertension. 2-kidney, 2-clip induced hypertension, genistein, sodium orthovanadate, and captopril vs. Sham control rat cells was evaluated on Intracellular chloride concentration ([Cl(-)](i)) reduction after hypotonic perfusion. 2-kidney, 2-clip hypertension for 1-12 weeks augmented hypotonic-induced intracellular chloride reduction in rat cerebrovascular smooth muscle cells, which captopril therapy completely reversed.
Synapse has enriched 10 related papers. Consider them for comparative context: